Rossari Biotech Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
521.00 +12.30 (2.42%)Updated : 21 Jan 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 1,893.111,647.871,495.791,342.66
Other Net -5.82-9.77-16.74-11.50
Diluted Weighted Average Shares 5.545.535.545.52
Gain( Loss)on Saleof Assets -0.071.880.280.64
Depreciation/ Amortization 67.0760.3962.9348.06
Operating Income 187.19182.69160.09140.31
Net Income 136.38130.69107.2697.67
Income Availableto Com Excl Extra Ord 136.38130.69107.2697.67
Other Operating Expenses Total 17.3711.5220.3915.17
Net Income Before Taxes 185.19177.62144.22136.28
Minority Interest 0.000.000.00-0.02
Net Income After Taxes 136.38130.69107.2697.70
Income Availableto Com Incl Extra Ord 136.38130.69107.2697.67
Costof Revenue Total 1,433.301,293.531,171.311,105.04
Gross Profit 647.00537.03484.57377.93
Interest Inc( Exp) Net- Non- Op Total 3.892.820.596.82
Diluted Net Income 136.38130.69107.2697.67
DPS- Common Stock Primary Issue 0.500.500.500.50
Provisionfor Income Taxes 48.8146.9336.9638.58
period Type ----
Net Income Before Extra Items 136.38130.69107.2697.67
Total Revenue 2,080.291,830.561,655.881,482.97
period Length 12.0012.0012.0012.00
Revenue 2,080.291,830.561,655.881,482.97
Selling/ General/ Admin Expenses Total 375.37282.44241.16179.27
Diluted Normalized EPS 24.6423.3719.3416.99
Diluted EPS Excluding Extra Ord Items 24.6323.6219.3817.70
Unusual Expense( Income) --0.00-4.88
*All figures in crores except per share values
Recommended For You
Trending Stocks
283.10+13.15(4.87%)
12,238.00+201.20(1.67%)
1,406.05+12.65(0.91%)
1,345.85-29.50 (-2.14%)
3,761.00-72.00 (-1.88%)